23 February 2023 - Patients with rare diseases are experts in their health condition. They provide a unique perspective, and ...
15 February 2023 - Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative ...
10 January 2023 - Encouraging researchers and sponsors to simplify clinical trials and employ a fit for purpose protocol is ...
10 November 2022 - The use of generic drugs continues to increase, generating substantial savings for purchasers and improving affordable access ...
20 November 2022 - Biggest shake-up in pharma pricing in decades prompts companies to shelve some potential therapies. ...
27 October 2022 - Increasing the availability of safe and effective medicines for children is a key priority for the US ...
17 October 2022 - This guidance provides recommendations to sponsors regarding considerations for tissue agnostic drug development in oncology. ...
6 October 2022 - For decades, academic clinical trials consortia have collaborated to optimise outcomes for childhood cancers through evaluating incremental ...
12 September 2022 - We reviewed US FDA initial approvals (2019-2021) of small molecules and antibody-drug conjugates for oncologic indications. ...
25 August 2022 - Officials from the EMA tout the benefits of patient registries to support regulatory decision making for ...
19 August 2022 - The biosimilars market is poised to grow over the next decade. ...
1 August 2022 - Patients have a critical role in drug development, from identifying unmet medical needs to assessing meaningful ...
1 August 2022 - Complex innovative designs in clinical trials have the potential to increase efficiency and lower the cost of ...
28 July 2022 - Congress should pass the proposed Pharmaceutical Research Transparency Act of 2022 to mandate drug companies provide ...
26 July 2022 - Walker Burger is beside himself with worry. ...